Source: International Congress 2014 – Airway biomarkers
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Jain, C. Bradshaw, N. Herje, G. Crater (Gilbert, Chapel Hill, Morrisville, United States Of America). Repeatability of FeNO measurements with an airway inflammation monitor using the 6 second (6s) and the 10 second (10s) exhalation modes in children 6 to 10 years of age with asthma. Eur Respir J 2014; 44: Suppl. 58, 991

Member's Comments

No comment yet.

Related content which might interest you: Fractional exhaled nitric oxide (FeNO), Impulse Oscilometry (IOS) and clinical status in 4 to 7 years old asthmatic children Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Correlation between Arabic version of the asthma control test, forced expiratory volume at 1 s and exhaled nitric oxide in Tunisian asthmatic patients Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Normal values of exhaled nitric oxide at 50 mL/s – A revisit Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 The difference of FENO levels according to gender in healty subjects never smoked Source: International Congress 2014 – Airway biomarkers Year: 2014 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Asthma control test (ACT), fractionated exhaled nitric oxide (FeNO) and forced expiratory volume in 1 second (FEV1) correlation in asthma control Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Correlation of fractional exhaled nitric oxide (FeNO) and peripheral blood eosinophils (PBE) in refractory asthma Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Late Breaking Abstract - Management of asthma in pregnancy using fractional exhaled nitric oxide (FENO) to adjust inhaled corticosteroid (ICS) dose did not improve perinatal outcomes: the Breathing for Life Trial (BLT) Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 Interaction between airway calibre and exhaled NO: Impact on asthma control assessment Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 The association among inflammation-related genes, fractional exhaled nitric oxide (FeNO), and symptom severity in adult asthma: A structural equation model (SEM) Source: International Congress 2014 – Genes and environment in asthma and COPD Year: 2014 Airway hyperresponsiveness (AHR) of small airways assessed by impulse oscillation (IOS) in adult asthma Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 Further evidence that FeNO directed therapy reduces asthma exacerbations Source: International Congress 2014 – Airway biomarkers Year: 2014 Assessment of small airways dysfunction with impulse oscillometry, multiple flow nitric oxide and spirometry in the Wessex severe asthma cohort study Source: International Congress 2015 – Lung function: waiting to exhale... Year: 2015 Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Relationships between exhaled nitric oxide and atopic profiles (mono-sensitization/poly-sensitization) in asthmatic patients Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Different patterns of exhaled NO response to acute bronchodilation in asthma Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013